Poblete-Gutiérrez P, Wiederholt T, Merk H F, Frank J
Department of Dermatology, University Hospital Maastricht, The Netherlands.
Eur J Dermatol. 2006 May-Jun;16(3):230-40.
The porphyrias comprise a clinically and genetically heterogeneous group of diseases mostly arising from a genetically determined dysfunction of specific enzymes along the pathway of heme biosynthesis. Based on the occurrence or absence of cutaneous symptoms and life-threatening acute neurological attacks, the different types of porphyrias can either be classified into cutaneous and non-cutaneous forms or acute and non-acute forms. Establishing an accurate diagnosis might be difficult for two reasons: i) the porphyrias can manifest with a broad but unspecific spectrum of clinical symptoms mimicking several other disorders, and ii) biochemical examination of urine, feces, and blood can reveal overlapping findings. Fortunately, however, the advances in the fields of molecular genetics during recent years have provided us with the possibility of overcoming these diagnostic pitfalls. Therefore, in controversial cases the correct diagnosis can finally be made using molecular biological techniques. Due to the various facets of the porphyrias, diagnosis and treatment should always imply a close interdisciplinary collaboration to counsel and help patients and their families most efficiently.
卟啉病是一组临床和遗传异质性疾病,大多源于血红素生物合成途径中特定酶的遗传决定性功能障碍。根据是否出现皮肤症状和危及生命的急性神经发作,不同类型的卟啉病可分为皮肤型和非皮肤型或急性和非急性型。准确诊断可能存在困难,原因有二:其一,卟啉病可表现出广泛但不具特异性的临床症状谱,类似于其他多种疾病;其二,对尿液、粪便和血液进行生化检查可能会发现重叠的结果。然而,幸运的是,近年来分子遗传学领域的进展为我们提供了克服这些诊断陷阱的可能性。因此,在有争议的病例中,最终可使用分子生物学技术做出正确诊断。由于卟啉病具有多方面特点,诊断和治疗始终需要密切的跨学科协作,以便最有效地为患者及其家属提供咨询和帮助。